Search company, investor...

ArKal Medical

arkalmedical.com

Stage

Series B | Alive

Total Raised

$22.8M

Last Raised

$17.5M | 14 yrs ago

About ArKal Medical

Arkal Medical is developing a continuous blood glucose sensor for diabetes.

Headquarters Location

46575 Fremont Boulevard

Fremont, California, 94538,

United States

510-933-1950

Missing: ArKal Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ArKal Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ArKal Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ArKal Medical is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,902 items

ArKal Medical Patents

ArKal Medical has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/28/2006

10/2/2012

Diabetes, Insulin therapies, Autoimmune diseases, Blood tests, Rare diseases

Grant

Application Date

3/28/2006

Grant Date

10/2/2012

Title

Related Topics

Diabetes, Insulin therapies, Autoimmune diseases, Blood tests, Rare diseases

Status

Grant

ArKal Medical Frequently Asked Questions (FAQ)

  • Where is ArKal Medical's headquarters?

    ArKal Medical's headquarters is located at 46575 Fremont Boulevard, Fremont.

  • What is ArKal Medical's latest funding round?

    ArKal Medical's latest funding round is Series B.

  • How much did ArKal Medical raise?

    ArKal Medical raised a total of $22.8M.

  • Who are the investors of ArKal Medical?

    Investors of ArKal Medical include MedVenture Associates, Delphi Ventures, Thomas McNerney & Partners and Shellwater & Co..

  • Who are ArKal Medical's competitors?

    Competitors of ArKal Medical include Sotera Wireless, OptiScan Biomedical, Chimerix, GlySure, Vytrace and 10 more.

Compare ArKal Medical to Competitors

A
Advanced BioSensors

Advanced BioSensors is developing a miniaturized blood glucose sensor for use in the treatment of diabetes.

L
Luminous Medical

Luminous Medical is developing a new device to allow the near continuous measurement of blood glucose and other analytes in the hospital environment.

G
Glucose Sensing Technologies

Vytrace Corporation (fka Glucose Sensing Technologies) is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

V
Vytrace

Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. Vytrace Corporation is developing a new critical care monitor to monitor glucose at the bedside of critically ill patients in the Intensive Care Unit. The product is designed specifically for patients in the ICU. This is not a consumer product for diabetic glucose monitoring. They also are exploring other analytes that may be monitored with their sensor technology. Vytrace Corporation has a highly accurate bedside monitor that automatically and continuously monitors blood glucose via a fiberoptic catheter with a photonic crystal sensor on the tip.

S
Sotera Wireless

Sotera Wireless is committed to the development, marketing and sale of a new generation early detection surveillance monitoring system. Its flagship product, the ViSi Mobile, is designed to improve patient safety by detecting early signs of deterioration in virtually any care setting, enabling early intervention and rapid response without limiting the patient's freedom of movement

I
IntelliDx

IntelliDx, Inc. is a development stage medical device company focused on the commercialization of an automated blood glucose monitoring device.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.